Stable-isotope trapping and high-throughput screenings of reactive metabolites using the isotope MS signature

被引:110
作者
Yan, ZY [1 ]
Caldwell, GW [1 ]
机构
[1] Johnson & Johnson Pharmaceut Res & Dev LLC, Div Drug Discovery, Spring House, PA 19477 USA
关键词
D O I
10.1021/ac040159k
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A highly efficient method has been developed to detect and identify reactive metabolites, using stable-isotope trapping combined with ESI-MS/MS neutral loss scanning. A mixture of glutathione (GSH, gamma-glutamylcysteinylglycine) and the stable-isotope labeled compound (GSX, gamma-glutamylcysteinylglycine-C-13(2)-N-15) was used at an equal molar ratio to trap reactive metabolites generated in microsomal incubations. Samples resulting from incubations were cleaned and concentrated by SPE, followed by LC-MS/MS analyses using constant neutral loss scanning for 129 Da (the gamma-glutamyl moiety) to detect formed GSH conjugates. Unambiguous identification of glutathione adducts was greatly facilitated by the presence of a unique MS signature of a prominent isotopic doublet that differs in mass by 3 Da. Further structural characterization of conjugates was achieved with high confidence by subsequently acquiring MS/MS spectra that were featured by neutral losses of 75 and 129 Da for GSH adducts and 78 and 129 Da for isotopic GSX adducts. The reliability of this method was vigorously validated using a number of compounds known to form reactive metabolites. Superior sensitivity was demonstrated by the capability of the current approach to identify reactive metabolites at low abundance. Because of the unique isotopic MS signature, ultrafast analyses of reactive metabolites were accomplished by direct injection of cleaned samples into mass spectrometers for neutral loss scanning. More importantly, this study has demonstrated the feasibility of the current method for completely automated detection of reactive metabolites via computer-assisted pattern recognition.
引用
收藏
页码:6835 / 6847
页数:13
相关论文
共 26 条
[1]   MASS-SPECTROMETRY IN THE ANALYSIS OF GLUTATHIONE CONJUGATES [J].
BAILLIE, TA ;
DAVIS, MR .
BIOLOGICAL MASS SPECTROMETRY, 1993, 22 (06) :319-325
[2]   17 beta-Estradiol metabolism by hamster hepatic microsomes: Comparison of catechol estrogen O-methylation with catechol estrogen oxidation and glutathione conjugation [J].
Butterworth, M ;
Lau, SS ;
Monks, TJ .
CHEMICAL RESEARCH IN TOXICOLOGY, 1996, 9 (04) :793-799
[3]  
Chen WCG, 2001, ADV EXP MED BIOL, V500, P521
[4]   The chemistry, toxicology, and identification in rat and human urine of 4-hydroxy-5-phenyl-1,3-oxazaperhydroin-2-one: A reactive metabolite in felbamate bioactivation [J].
Dieckhaus, CM ;
Santos, WL ;
Sofia, RD ;
Macdonald, TL .
CHEMICAL RESEARCH IN TOXICOLOGY, 2001, 14 (08) :958-964
[5]   Drug-protein adducts: An industry perspective on minimizing the potential for drug bioactivation in drug discovery and development [J].
Evans, DC ;
Watt, AP ;
Nicoll-Griffith, DA ;
Baillie, TA .
CHEMICAL RESEARCH IN TOXICOLOGY, 2004, 17 (01) :3-16
[6]   Bioactivation of estrone and its catechol metabolites to quinoid-glutathione conjugates in rat liver microsomes [J].
Iverson, SL ;
Shen, L ;
Anlar, N ;
Bolton, JL .
CHEMICAL RESEARCH IN TOXICOLOGY, 1996, 9 (02) :492-499
[7]  
Ju C., 2002, Current Drug Metabolism, V3, P367, DOI 10.2174/1389200023337333
[8]   Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission [J].
Kassahun, K ;
Pearson, PG ;
Tang, W ;
McIntosh, L ;
Leung, K ;
Elmore, C ;
Dean, D ;
Wang, R ;
Doss, G ;
Baillie, TA .
CHEMICAL RESEARCH IN TOXICOLOGY, 2001, 14 (01) :62-70
[9]   Incidence of adverse drug reactions in hospitalized patients - A meta-analysis of prospective studies [J].
Lazarou, J ;
Pomeranz, BH ;
Corey, PN .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (15) :1200-1205
[10]  
Li AP, 1999, BRIT J CLIN PHARMACO, V48, P733